Related Experiment Videos
[Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors]
1Institutionen för tumörbiologi, Karolinska institutet, Stockholm.
Abstract:
The RB and p53 tumour suppressor genes encode nuclear proteins that exert an inhibitive effect on cell growth. A large variety of human tumour types manifest loss or mutation of the RB or p53 genes, and p53 mutation is the commonest genetic alteration found in tumour cells. In addition, the RB and p53 proteins may be inactivated by complex formation with viral oncoproteins--for instance, in the case of cervical carcinoma carrying human papilloma virus. In vivo introduction of an intact RB or p53 gene into malignant cells lacking the respective gene results in suppression of the neoplastic phenotype and thus of tumourigenicity, p53 being the more potent of the two in this respect. Further elucidation of tumour suppressor genes may well result in future improvement in the diagnosis and treatment of cancer.
Insights
Tumor suppressor genes like RB and p53 inhibit cell growth. Restoring these genes in cancer cells can suppress tumor formation, offering potential for cancer treatment.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Context:
- The RB and p53 genes are critical tumor suppressors.
- Loss or mutation of RB/p53 is common in human cancers.
- Viral oncoproteins can inactivate RB and p53 proteins.
Purpose:
- To investigate the role of RB and p53 tumor suppressor genes in cancer.
- To explore the therapeutic potential of restoring tumor suppressor gene function.
Summary:
- RB and p53 encode nuclear proteins that inhibit cell growth.
- Gene therapy introducing functional RB or p53 suppressed tumor growth in vivo.
- p53 demonstrated greater potency in suppressing the neoplastic phenotype.
Impact:
- Elucidating tumor suppressor gene function is crucial for cancer research.
- This research may lead to improved cancer diagnosis and treatment strategies.
- Gene restoration offers a promising avenue for targeted cancer therapies.